Profitability UncertaintyThe timing of profitability, disruptions due to the Israel-Hamas war, changes to US federal laws and Canadian reform to the Cannabis Act are unclear.
Regulatory ChallengesRegulatory challenges, including unclear US federal cannabis reform and changes to the Canadian Cannabis Act, are significant factors that negatively impact the stock's valuation.
Valuation ConcernsCronos Group's enterprise value is slightly negative, attributed to the lack of US reform and investor restrictions, which pressures the stock compared to its peers.